Get started
Author

Florian W. Adraoui

Institution: Biotrial (France)
Observed institution: Biotrial (France)
ORCID: 0009-0004-0563-8932
Observed ORCID: 0009-0004-0563-8932
OpenAlex ID: A5076761804
Connecting Neurobiological Features with Interregional Dysconnectivity in Social-Cognitive Impairments of Schizophrenia
2023 · Florian W. Adraoui, Linda Douw, et al. · International Journal of Molecular Sciences · 15
PDF
Differential Effects of Aripiprazole on Electroencephalography-Recorded Gamma-Band Auditory Steady-State Response, Spontaneous Gamma Oscillations and Behavior in a Schizophrenia Rat Model
2024 · Florian W. Adraoui, Kenza Hettak, et al. · International Journal of Molecular Sciences · 7
PDF
Clozapine mitigates MK-801-induced mismatch negativity impairment in a rat electroencephalography study: relevance for schizophrenia drug development
2025 · Florian W. Adraoui, Maëlle Violas, et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 4
KETAMIR-2, a new molecular entity and novel ketamine analog
2025 · Itzchak Angel, Rita Perelroizen, et al. · Frontiers in Pharmacology · 4
PDF
Detecting drug-induced EEG alterations with machine learning: A methodological proof-of-concept study in rats treated with MK-801
2026 · Matthieu Basset, Paul-Emeric Saunier, et al. · Journal of Pharmacological and Toxicological Methods · 1
Differential effects of cariprazine, LY379268 and donepezil on EEG oscillations and auditory steady-state response in MK-801-treated rats: relevance for schizophrenia drug development
2026 · Florian W. Adraoui, Maëlle Violas, et al. · Neuropharmacology · 1
Corrigendum to ‘Clozapine mitigates MK-801-induced mismatch negativity impairment in a rat electroencephalography study: relevance for schizophrenia drug development’
2026 · Florian W. Adraoui, Maëlle Violas, et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Works count: 7
Citation count: 32
H-index: 4
I10-index: 1
Year
Topic
Type